Identification of new CRY modulators and their characterization will facilitate the understanding and regulation of CRY protein functions in gene expression,49 metabolism,7,10,11,13,50,51 cancer,12,52–54 and sleep-wake rhythms,55–57 ultimately leading to the discovery of therapeutic agents for circadian clock-related diseases. The gene discussed is CRYL1; the disease is cancer.